End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

The hospitals segment held the largest share of the nephrology and urology devices market, accounting for 44.5% share in 2026. Hospitals remain major centers for diagnosing and treating complex kidney and urinary conditions because they provide comprehensive clinical infrastructure, specialized specialists, imaging capabilities, and surgical facilities. Their ability to support both routine and complex urological interventions makes hospitals important users of nephrology and urology devices across diagnostic, therapeutic, and surgical procedures. Increasing demand for effective management of urinary disorders and the continued use of advanced minimally invasive techniques further support device utilization in hospital settings.

Ambulatory surgical centers are expected to be the fastest-growing end-use segment as urological procedures increasingly shift toward outpatient and minimally invasive care environments. These facilities can provide focused procedural services while supporting shorter treatment pathways and efficient use of healthcare resources. Advances in urological technologies are enabling a wider range of interventions to be performed outside traditional inpatient settings, creating additional opportunities for device adoption. The growing preference for convenient procedural care and efficient healthcare delivery is consequently strengthening demand from ambulatory surgical centers.

Application Segment Analysis: Urolithiasis (Largest Segment) vs Kidney Diseases (Fastest-Growing Segment)

Urolithiasis represented the largest application segment of the nephrology and urology devices market in 2026, reflecting the substantial clinical need for devices used in the diagnosis and treatment of urinary stones. Management of stone-related conditions frequently requires specialized instruments and minimally invasive interventions, creating sustained demand for urological devices across healthcare facilities. The availability of advanced procedural technologies supports efficient stone management while reducing the need for more invasive approaches. Continued clinical attention to urinary stone conditions and the growing use of device-assisted interventions reinforce the segment's established market position.

The kidney diseases segment is anticipated to register the fastest growth as healthcare systems place greater emphasis on early diagnosis, ongoing disease management, and advanced treatment options for renal conditions. Rising clinical focus on preserving kidney function and improving outcomes is encouraging the use of specialized diagnostic and therapeutic technologies. The increasing complexity of kidney-related care also creates opportunities for devices that support minimally invasive procedures and targeted interventions. As treatment pathways continue to evolve, kidney disease applications are gaining greater importance within the nephrology and urology device landscape.